12-85055721-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000393217.7(LRRIQ1):āc.928C>Gā(p.Gln310Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000186 in 1,603,996 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000393217.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRRIQ1 | NM_001079910.2 | c.928C>G | p.Gln310Glu | missense_variant | 8/27 | ENST00000393217.7 | NP_001073379.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRRIQ1 | ENST00000393217.7 | c.928C>G | p.Gln310Glu | missense_variant | 8/27 | 1 | NM_001079910.2 | ENSP00000376910.2 | ||
LRRIQ1 | ENST00000525971.6 | n.1046C>G | non_coding_transcript_exon_variant | 8/17 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000166 AC: 25AN: 150376Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000181 AC: 44AN: 242634Hom.: 0 AF XY: 0.000145 AC XY: 19AN XY: 131314
GnomAD4 exome AF: 0.000188 AC: 273AN: 1453504Hom.: 2 Cov.: 34 AF XY: 0.000188 AC XY: 136AN XY: 722704
GnomAD4 genome AF: 0.000166 AC: 25AN: 150492Hom.: 0 Cov.: 32 AF XY: 0.000123 AC XY: 9AN XY: 73394
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 14, 2023 | The c.928C>G (p.Q310E) alteration is located in exon 8 (coding exon 7) of the LRRIQ1 gene. This alteration results from a C to G substitution at nucleotide position 928, causing the glutamine (Q) at amino acid position 310 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at